Login / Signup

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.

Adrian SacherPatricia LoRussoManish R PatelWilson H MillerElena GarraldaMartin D ForsterArmando SantoroAlejandro FalconTae Won KimLuis Paz-AresSamantha BowyerMaria de MiguelSae-Won HanMatthew G KrebsJong-Seok LeeMichael L ChengKathryn ArbourErminia MassarelliYoonha ChoiZhen ShiSandhya MandlekarMark T LinStephanie Royer-JooJulie ChangNeekesh V DhariaJennifer L SchutzmanJayesh Desainull null
Published in: The New England journal of medicine (2023)
G12C-positive tumors, with mostly low-grade adverse events. (Funded by Genentech; ClinicalTrials.gov number, NCT04449874.).
Keyphrases
  • low grade
  • high grade
  • wild type